KANUMA

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug KANUMA contains one active pharmaceutical ingredient (API):

1 Sebelipase alfa UNII K4YTU42T8G - SEBELIPASE ALFA

Sebelipase alfa is a recombinant human lysosomal acid lipase (rhLAL). Replacement of LAL enzyme activity leads to reductions in liver fat content and transaminases, and enables metabolism of cholesteryl esters and triglycerides in the lysosome, leading to reductions in lowdensity lipoprotein (LDL) cholesterol and non-high-density lipoprotein (HDL) cholesterol, triglycerides, and increases in HDL cholesterol. Improvement in growth occurs as a result of substrate reduction in the intestine. Read about Sebelipase alfa

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KANUMA Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AB14		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 565518060000101
Country: CA	Health Products and Food Branch	Identifier(s): 02469596
Country: EE	Ravimiamet	Identifier(s): 1695225
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1151033001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 412241
Country: FR	Base de données publique des médicaments	Identifier(s): 68773758
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 309327
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8012
Country: IT	Agenzia del Farmaco	Identifier(s): 044493017
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1077965
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 137464
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100354137
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69025001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680131470068
Country: US	FDA, National Drug Code	Identifier(s): 25682-007